Elixinol Wellness Limited (ASX:EXL)

Elixinol Wellness Statistics

Total Valuation

ASX:EXL has a market cap or net worth of AUD 3.32 million. The enterprise value is 5.34 million.

Market Cap	3.32M
Enterprise Value	5.34M

Important Dates

The next estimated earnings date is Friday, November 28, 2025.

Earnings Date	Nov 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:EXL has 276.99 million shares outstanding. The number of shares has increased by 105.12% in one year.

Current Share Class	276.99M
Shares Outstanding	276.99M
Shares Change (YoY)	+105.12%
Shares Change (QoQ)	+20.50%
Owned by Insiders (%)	16.52%
Owned by Institutions (%)	13.02%
Float	216.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.21
PB Ratio	0.48
P/TBV Ratio	3.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-2.59
EV / Sales	0.34
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.95

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 0.45.

Current Ratio	0.92
Quick Ratio	0.36
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	-1.14
Interest Coverage	-13.11

Financial Efficiency

Return on equity (ROE) is -28.60% and return on invested capital (ROIC) is -37.28%.

Return on Equity (ROE)	-28.60%
Return on Assets (ROA)	-24.18%
Return on Invested Capital (ROIC)	-37.28%
Return on Capital Employed (ROCE)	-55.34%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.10
Inventory Turnover	2.93

Taxes

Income Tax	-3.59M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -62.50% in the last 52 weeks. The beta is 2.26, so ASX:EXL's price volatility has been higher than the market average.

Beta (5Y)	2.26
52-Week Price Change	-62.50%
50-Day Moving Average	0.01
200-Day Moving Average	0.02
Relative Strength Index (RSI)	40.08
Average Volume (20 Days)	424,343

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:EXL had revenue of AUD 15.85 million and -2.06 million in losses. Loss per share was -0.01.

Revenue	15.85M
Gross Profit	5.67M
Operating Income	-5.57M
Pretax Income	-5.65M
Net Income	-2.06M
EBITDA	-5.19M
EBIT	-5.57M
Loss Per Share	-0.01

Balance Sheet

The company has 1.09 million in cash and 3.11 million in debt, giving a net cash position of -2.02 million or -0.01 per share.

Cash & Cash Equivalents	1.09M
Total Debt	3.11M
Net Cash	-2.02M
Net Cash Per Share	-0.01
Equity (Book Value)	6.97M
Book Value Per Share	0.03
Working Capital	-551,000

Cash Flow

In the last 12 months, operating cash flow was -2.71 million and capital expenditures -28,000, giving a free cash flow of -2.74 million.

Operating Cash Flow	-2.71M
Capital Expenditures	-28,000
Free Cash Flow	-2.74M
FCF Per Share	-0.01

Margins

Gross margin is 35.78%, with operating and profit margins of -35.16% and -12.99%.

Gross Margin	35.78%
Operating Margin	-35.16%
Pretax Margin	-35.64%
Profit Margin	-12.99%
EBITDA Margin	-32.75%
EBIT Margin	-35.16%
FCF Margin	n/a

Dividends & Yields

ASX:EXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-105.12%
Shareholder Yield	-105.12%
Earnings Yield	-61.95%
FCF Yield	-82.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 2, 2024. It was a reverse split with a ratio of 0.125.

Last Split Date	Dec 2, 2024
Split Type	Reverse
Split Ratio	0.125

Scores

ASX:EXL has an Altman Z-Score of -19.3 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-19.3
Piotroski F-Score	2